1. 1398PReal-world progression-free survival of patients on anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) for ALK+ non-small cell lung cancer (NSCLC). (23rd October 2018) Authors: Jahanzeb, M; Lin, H M; Pan, X; Yin, Y; Hou, P; Nordstrom, B L; Desai, A; Socinski, M A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 907PMatch-adjusted indirect comparison of durvalumab and chemotherapy for locally advanced or metastatic urothelial carcinoma (UC) following failure of platinum-based therapy. (23rd October 2018) Authors: Hoyle, C K; Klein, A B; Patel, K A; Shire, N; Wang, H; Chu, B C; Ouwens, M; Nordstrom, B L; Horne, L; Arkenau, H-T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗